stocks logo

UTMD Valuation

Utah Medical Products Inc
$
62.210
+0.15(0.242%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

UTMD Relative Valuation

UTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UTMD is overvalued; if below, it's undervalued.
Intellectia AI SwingMax

Historical Valuation

Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:62.21
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Utah Medical Products Inc. (UTMD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Utah Medical Products Inc. (UTMD) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Utah Medical Products Inc. (UTMD) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Utah Medical Products Inc. (UTMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Utah Medical Products Inc. (UTMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Utah Medical Products Inc (UTMD) has a current Price-to-Book (P/B) ratio of 1.70. Compared to its 3-year average P/B ratio of 2.26 , the current P/B ratio is approximately -24.55% higher. Relative to its 5-year average P/B ratio of 2.59, the current P/B ratio is about -34.27% higher. Utah Medical Products Inc (UTMD) has a Forward Free Cash Flow (FCF) yield of approximately 6.92%. Compared to its 3-year average FCF yield of 6.67%, the current FCF yield is approximately 3.76% lower. Relative to its 5-year average FCF yield of 6.48% , the current FCF yield is about 6.75% lower.
1.70
P/B
Median3y
2.26
Median5y
2.59
6.92
FCF Yield
Median3y
6.67
Median5y
6.48
AI Stock Picker

Competitors Valuation Multiple

The average P/S ratio for UTMD's competitors is 3.54, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -4.30%, this premium appears unsustainable.
Financial AI Agent

Performance Decomposition

1Y
3Y
5Y
Market capitalization of UTMD decreased by 6.16% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 15.69 to 16.61.
The secondary factor is the Revenue Growth, contributed -4.30%to the performance.
Overall, the performance of UTMD in the past 1 year is driven by P/E Change. Which is more unsustainable.
-4.30%
10.40M → 9.95M
Revenue Growth
+
-7.77%
33.20 → 30.62
Margin Expansion
+
5.91%
15.69 → 16.61
P/E Change
=
-6.16%
66.29 → 62.21
Mkt Cap Growth

FAQ

arrow icon

Is Utah Medical Products Inc (UTMD) currently overvalued or undervalued?

Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation methord.
arrow icon

What is Utah Medical Products Inc (UTMD) fair value?

arrow icon

How does UTMD's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Utah Medical Products Inc (UTMD) as of Sep 01 2025?

arrow icon

What is the current FCF Yield for Utah Medical Products Inc (UTMD) as of Sep 01 2025?

arrow icon

What is the current Forward P/E ratio for Utah Medical Products Inc (UTMD) as of Sep 01 2025?

arrow icon

What is the current Forward P/S ratio for Utah Medical Products Inc (UTMD) as of Sep 01 2025?